BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26827390)

  • 1. "Bringing a Butter Knife to a Gun Fight"? Salience, Disclosure, and FDA's Differing Approaches to the Tobacco Use and Obesity Epidemics.
    Weimholt J
    Food Drug Law J; 2015; 70(4):501-51, i. PubMed ID: 26827390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.
    Chaloupka FJ; Warner KE; Acemoğlu D; Gruber J; Laux F; Max W; Newhouse J; Schelling T; Sindelar J
    Tob Control; 2015 Mar; 24(2):112-9. PubMed ID: 25550419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA withdraws from fight over graphic warning labels on cigarette packs.
    Printz C
    Cancer; 2013 Jul; 119(13):2361. PubMed ID: 23775432
    [No Abstract]   [Full Text] [Related]  

  • 4. Should Graphic Warning Labels Proposed for Cigarette Packages Sold in the United States Mention the Food and Drug Administration?
    Jovanova M; Skurka C; Byrne S; Kalaji M; Greiner Safi A; Porticella N; Mathios AD; Avery RJ; Dorf MC; Niederdeppe J
    Nicotine Tob Res; 2021 Jan; 23(2):402-406. PubMed ID: 32770222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual gut punch: persuasion, emotion, and the constitutional meaning of graphic disclosure.
    Goodman EP
    Cornell Law Rev; 2014; 99(3):513-69. PubMed ID: 24745102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 May; 81(90):28973-9106. PubMed ID: 27192730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FDA's graphic tobacco warnings and the first amendment.
    Orentlicher D
    N Engl J Med; 2013 Jul; 369(3):204-6. PubMed ID: 23803137
    [No Abstract]   [Full Text] [Related]  

  • 8. Graphic warning labels and the demand for cigarettes.
    Starr MA; Drake K
    Tob Control; 2017 Mar; 26(2):169-174. PubMed ID: 27015879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
    Jenson D; Lester J; Berman ML
    Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The argument in favor of graphic warning labels on cigarette packages.
    Pakhale S; Leone F; White AC;
    Ann Am Thorac Soc; 2013 Feb; 10(1):50-2. PubMed ID: 23509332
    [No Abstract]   [Full Text] [Related]  

  • 11. Further amendments to general regulations of the Food and Drug Administration to incorporate tobacco products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(22):5171-6. PubMed ID: 22359802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Cigarette Sales: State Differences in FDA Advertising and Labeling Violations, 2014, United States.
    Baker HM; Lee JG; Ranney LM; Goldstein AO
    Nicotine Tob Res; 2016 Feb; 18(2):221-6. PubMed ID: 25744967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of legal and scientific issues in court challenges to graphic tobacco warnings.
    Kraemer JD; Baig SA
    Am J Prev Med; 2013 Sep; 45(3):334-42. PubMed ID: 23953361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis.
    Huang J; Chaloupka FJ; Fong GT
    Tob Control; 2014 Mar; 23 Suppl 1(0 1):i7-12. PubMed ID: 24218057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA-Required Tobacco Product Inserts & Onserts–and the First Amendment.
    Lindblom EN; Berman ML; Thrasher JF
    Food Drug Law J; 2017; 72(1):1-25. PubMed ID: 29140651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public support for graphic health warning labels in the U.S.
    Kamyab K; Nonnemaker JM; Farrelly MC
    Am J Prev Med; 2015 Jan; 48(1):89-92. PubMed ID: 25217818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco companies are evading FDA ban on "light" cigarette labeling, finds study.
    Mayor S
    BMJ; 2013 Mar; 346():f1806. PubMed ID: 23512764
    [No Abstract]   [Full Text] [Related]  

  • 19. Compelled commercial speech: the Food and Drug Administration's effort to smoke out the tobacco industry through graphic warning labels.
    Haynes BM; Andrews AH; Jacob CR
    Food Drug Law J; 2013; 68(4):329-56, i. PubMed ID: 24552078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FDA and graphic cigarette-pack warnings--thwarted by the courts.
    Bayer R; Johns D; Colgrove J
    N Engl J Med; 2013 Jul; 369(3):206-8. PubMed ID: 23803139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.